Low AMH, or low anti-Müllerian hormone, is a blood-test finding that suggests the ovaries have a reduced pool of recruitable follicles. AMH is produced by small growing follicles in the ovaries, so the level gives fertility specialists a practical estimate of ovarian reserve. It does not measure egg quality, and it does not diagnose infertility on its own. A woman can have low AMH and still ovulate regularly, have periods, and even conceive naturally, especially if she is younger.

Doctors use AMH to guide counselling, medication planning, and expectations for IVF or egg freezing. In Indian practice, the result is interpreted along with age, ultrasound antral follicle count (AFC), menstrual history, and partner semen analysis rather than in isolation.

Low AMH is most commonly due to a natural decline in ovarian reserve with age, especially after 30 and more noticeably after 35. Some women have a genetically earlier decline in egg supply, which can run in families. Other causes include previous ovarian surgery, endometriosis, chemotherapy, radiation, smoking, and certain autoimmune conditions. In some women, the ovaries may be functioning normally but AMH is low because the follicle pool is smaller than average.

Importantly, low AMH is not usually caused by stress, travel, or routine lifestyle factors. However, long-term smoking, severe obesity or underweight status, and untreated medical illness can worsen reproductive outcomes overall. In India, many patients discover low AMH during infertility workup, after repeated cycle delays, or when planning a late pregnancy.

Low AMH often has no obvious symptoms. Many women feel completely well and only learn about it after a fertility test. When symptoms do appear, they are usually related to the underlying cause or to diminished ovarian reserve, such as shorter menstrual cycles, lighter periods, difficulty conceiving, or a history of earlier-than-expected menopause in the family. Some women with endometriosis or prior ovarian surgery may also have pelvic pain or painful periods.

Because AMH is a hormone marker rather than a symptom-based diagnosis, the key clue is often a fertility concern: trying to conceive for 6-12 months without success, or earlier if the woman is over 35, has irregular cycles, or has had ovarian surgery.

Low AMH mainly affects fertility by predicting how many eggs may be available to respond during ovarian stimulation. It can mean fewer follicles grow in an IVF cycle, fewer eggs are collected, and sometimes more than one cycle is needed to create embryos. In women who still ovulate, low AMH does not necessarily reduce the chance of natural conception in a given month as much as it affects treatment planning.

Age remains the single most important predictor of egg quality and pregnancy chance. So a 28-year-old with low AMH may have a better outlook than a 40-year-old with the same value. In Indian fertility clinics, we counsel patients that low AMH is a planning signal, not a verdict. If time is important, earlier evaluation and treatment can improve the overall chance of success.

Diagnosis starts with a detailed fertility history and a few targeted tests. AMH is measured by a simple blood test, usually on any day of the cycle. The result is interpreted with transvaginal ultrasound for antral follicle count (AFC), and often FSH and estradiol on day 2 or 3 of the period. A semen analysis is essential for the partner, and thyroid, prolactin, and vitamin D may be checked depending on the case.

Typical interpretation varies by age and lab, but generally lower AMH suggests a reduced ovarian response. A fertility specialist may also review prior pregnancies, ovarian surgery, endometriosis, PCOS features, and planned timeline. HomeIVF can coordinate these tests with home collection or local partner labs where available, reducing travel stress for patients in Indian cities and tier-2 locations.

Treatment depends on age, how low the AMH is, symptoms, and how long you have been trying. If ovulation is present and the couple has not been trying long, doctors may recommend timed intercourse or ovulation induction. For some couples, IUI is useful when sperm parameters and tubes are acceptable, though success may be lower when ovarian reserve is very low. IVF is often the most efficient option when time is limited, the woman is older, or there are additional factors such as tubal disease or male factor infertility.

Supportive care includes lifestyle optimisation, stopping smoking, weight management, and treating thyroid or prolactin issues. Supplements should be used only after medical advice; evidence for many fertility supplements is limited. In India, treatment selection is also shaped by affordability, so many couples choose a stepwise plan that balances success probability and cost.

IVF success in low AMH depends strongly on age, AFC, embryo quality, and the cause of low reserve. Low AMH usually means fewer eggs retrieved, but it does not automatically mean poor pregnancy outcomes if a good embryo is obtained. In typical Indian practice, younger women with low AMH may still have reasonable success rates per transfer, while women above 38 often need more than one cycle because egg quality declines with age.

Typical Indian counselling ranges: clinical pregnancy rates per IVF transfer may be roughly 20-40% in younger patients with low AMH, and lower in older age groups; live birth rates are often lower than pregnancy rates and vary by centre. There is no honest single percentage for all low AMH cases. Costs are commonly about INR 1.2 lakh to 2.8 lakh per IVF cycle, with higher medication costs if ovarian reserve is low. HomeIVF focuses on personalised stimulation, realistic counselling, and efficient cycle planning to avoid unnecessary delays.

HomeIVF’s approach for low AMH starts with a clear fertility roadmap, not guesswork. We assess age, AMH, AFC, prior cycle history, semen analysis, and timelines, then recommend the most efficient path—whether that is trying naturally for a short period, timed intercourse, IUI, or moving directly to IVF. Because low AMH patients often benefit from earlier action, counselling is designed to reduce time lost between testing, stimulation, and treatment.

Where suitable, HomeIVF helps patients arrange diagnostics, medicines guidance, cycle monitoring, and coordinated specialist review with a patient-friendly, India-aware plan. We also discuss realistic expectations about egg numbers, the possibility of multiple cycles, and budget planning upfront so couples can make informed decisions without pressure.

See a fertility specialist if you are under 35 and have been trying for 12 months, or over 35 and have been trying for 6 months. You should seek earlier review if you have irregular periods, known endometriosis, prior ovarian surgery, chemotherapy exposure, recurrent miscarriage, or a family history of early menopause. A low AMH result itself is also a good reason to consult sooner, especially if you are planning pregnancy in the next 6-12 months.

Urgent assessment is sensible if your periods are becoming much shorter, you have been told your AFC is low, or you are considering egg freezing. Early consultation does not guarantee pregnancy, but it often improves planning, avoids delays, and helps choose the most effective treatment for your age and reserve profile.